These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3651856)

  • 41. Aminophylline, respiratory muscle strength and exercise tolerance in chronic obstructive airway disease.
    Cooper CB; Davidson AC; Cameron IR
    Bull Eur Physiopathol Respir; 1987; 23(1):15-22. PubMed ID: 3297214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect duration and treatment effectiveness of salmeterol, fenoterol and salbutamol in severe forms of respiratory tract obstruction].
    Vollmer M; Schmidt EW; Ulmer WT
    Pneumologie; 1995 Oct; 49(10):528-34. PubMed ID: 8584522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of aminophylline, oxyphylline and fenoterol on some ventilatory functions in patients with reversible airways obstruction.
    Král B; Eliás J; Ilnerová A; Tilser P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1983; 26(5):535-43. PubMed ID: 6599174
    [No Abstract]   [Full Text] [Related]  

  • 44. [Broncholytic activity of dose-adjusted aerosols in active respiratory tuberculosis].
    Vizel' AA; Iaushev MF; Mustafin RR; Goncharova LV
    Probl Tuberk; 1995; (2):7-9. PubMed ID: 7777469
    [No Abstract]   [Full Text] [Related]  

  • 45. [Obstructive respiratory diseases. Comparisons of dose effectiveness of Fenoterol (Berotec) given in diverse oral administration forms].
    Hertwig B
    ZFA (Stuttgart); 1979 Jan; 55(2):113-22. PubMed ID: 425634
    [No Abstract]   [Full Text] [Related]  

  • 46. [The cholinergic component of airway obstruction].
    Ulmer WT; Schwabl U
    Fortschr Med; 1987 Jan; 105(3):43-7. PubMed ID: 2951304
    [No Abstract]   [Full Text] [Related]  

  • 47. The influence of ketotifen and aminophylline on the central and peripheral airways.
    Dorow P; Schiess W
    Arzneimittelforschung; 1983; 33(2):265-8. PubMed ID: 6682668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fenoterol plus ipratropium ('Duovent') aerosol therapy delivered by a tube spacer.
    Woodcock A; Humberstone A; Sutton B; Law A; Lytton S; Newey M; Pike S
    Pharmatherapeutica; 1984; 4(1):32-5. PubMed ID: 6239292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of nebulized bronchodilators in infants under 1 year of age: analysis of four forms of therapy.
    Mallol J; Barrueto L; Girardi G; Muñoz R; Puppo H; Ulloa V; Toro O; Quevedo F
    Pediatr Pulmonol; 1987; 3(5):298-303. PubMed ID: 2959900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nebulized fenoterol versus i.v. aminophylline treatment of acute severe asthma.
    Pan JF; Yang PC; Chang DB; Yu CJ; Lee LN; Kuo SH
    Am J Emerg Med; 1995 Nov; 13(6):677-80. PubMed ID: 7575813
    [No Abstract]   [Full Text] [Related]  

  • 51. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?].
    Musil J; Hirsch V; Vondra V; Reisová M
    Vnitr Lek; 1998 Jul; 44(7):415-7. PubMed ID: 9748878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Lung functions and blood levels after parenteral administration of theophylline-ethylenediamine (author's transl)].
    Wiessmann KJ; Schulz HU
    Dtsch Med Wochenschr; 1977 Dec; 102(52):1916-20. PubMed ID: 598301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of nebulized fenoterol on spirometry, dyspnea sensation changes during exercise in patients with chronic obstructive pulmonary disease.
    Chiang LL; Yu CT; Kuo HP
    Changgeng Yi Xue Za Zhi; 1996 Jun; 19(2):129-34. PubMed ID: 8828254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of a fenoterol/ipratropium combination with salbutamol from metered dose inhalers in subjects with chronic partially reversible airways obstruction.
    Crane J; Gamble S; Purdie G
    N Z Med J; 1987 Jun; 100(826):385-7. PubMed ID: 2967448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Fenoterol in chronic obstructive bronchitis--comparison of the efficacy of various application forms. Advantages and disadvantages of metered dose inhalers with a small or large expander and a mechanical atomizer].
    Matthys H; Zaiss A; Ende K
    Fortschr Med; 1984 Oct; 102(39):996-9. PubMed ID: 6500458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of aerosols in obstructive respiratory tract diseases. Clinical-pharmacological studies using fenoterol, salbutamol, ipratropium bromide and terbutaline].
    Kaik G
    Schweiz Med Wochenschr; 1977 Dec; 107(52):1948-57. PubMed ID: 145654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bronchodilator effects on gastric acid secretion.
    Foster LJ; Trudeau WL; Goldman AL
    JAMA; 1979 Jun; 241(24):2613-5. PubMed ID: 439357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute effects of nifedipine on patients with chronic obstructive lung disease.
    Ikeda H; Takahashi K; Sasaki H; Ito E; Yasui S
    Arzneimittelforschung; 1985; 35(2):518-21. PubMed ID: 4039574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of Ditek in the treatment of patients with chronic obstructive bronchitis].
    Moskalev MN
    Klin Med (Mosk); 1996; 74(5):52-3. PubMed ID: 8999188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.